Newborn Screening Market Size, Share and Growth Outlook 2026: By Product Type (Instruments, Reagents, Consumables and Assay Kits), By Test Type, By Technology, By Disease, Companies to 2034.
The global Newborn Screening Market size is forecast to increase from $986.39 Million in 2026 to $1852.96 Million in 2034 at a CAGR of 8.2% between 2026 and 2034.
The Newborn Screening market report provides detailed analysis and outlook of Newborn Screening segments including By Product Type (Instruments, Reagents, Consumables and Assay Kits), By Test Type (Dry Blood Spot Tests, Hearing Screening Tests, Critical Congenital Heart Disease (CCHD) / Pulse Oximetry Screening Tests), By Technology (Tandem Mass Spectrometry, Immunoassays and Enzymatic Assays, Molecular/DNA Assays, Electrophoresis, Pulse Oximetry, Other Technologies ), By Disease (Critical Congenital Heart Disease (CCHD), Metabolic Disorders, Endocrine Disorders, Hematological Disorders, Cystic Fibrosis (CF), Other Genetic and Rare Disorders) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Newborn Screening Industry Overview
Genomic Technologies Expanding the Scope of Neonatal Diagnostics
The newborn screening industry is undergoing a major transformation as genomic technologies, molecular diagnostics, and precision medicine approaches expand the number of conditions that can be identified shortly after birth. Healthcare systems worldwide are moving beyond conventional biochemical screening toward more comprehensive diagnostic models capable of detecting a wider range of rare genetic, metabolic, and inherited disorders. Early identification of treatable diseases remains the primary objective of newborn screening programs, enabling timely intervention that can significantly improve long-term health outcomes. Advances in sequencing technologies, laboratory automation, and bioinformatics are supporting the evolution of newborn screening from targeted testing toward broader genomic assessment integrated within national healthcare systems.
Genome Sequencing Driving Next-Generation Screening Programs
A major industry trend is the incorporation of genomic sequencing into routine newborn screening workflows. The Rady Children’s Institute for Genomic Medicine expanded this movement through its collaboration with King Faisal Specialist Hospital & Research Centre to implement the BeginNGS® program. The initiative utilizes genome sequencing to screen newborns for more than 1,000 treatable genetic conditions, demonstrating the growing role of genomics in neonatal healthcare. Such programs represent a significant shift from traditional screening approaches by enabling earlier and more comprehensive disease detection. As sequencing technologies become increasingly accessible and clinically validated, healthcare organizations are exploring broader implementation of genomic newborn screening as part of precision medicine strategies aimed at improving disease prevention and early intervention outcomes.
Standardization and Public Health Integration Strengthening Industry Development
The industry is also benefiting from efforts to improve standardization, laboratory quality, and public health integration. Accredia's extension of ISO 15189 accreditation standards to laboratories performing neonatal screening supports greater consistency and reliability across Extended Newborn Screening programs capable of detecting more than 50 rare diseases from a single blood sample. At the same time, regional healthcare initiatives are incorporating advanced molecular technologies into population-wide screening efforts. Revvity is supporting this transition through its participation in Helyx Industries' Genome Project in Italy's Apulia region, where DNA-based analysis is being utilized to identify metabolic disorders and rare diseases at birth. These developments illustrate how newborn screening is increasingly becoming a technologically advanced, standardized, and genomics-driven public health service designed to improve early diagnosis and long-term patient outcomes.
Newborn Screening Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Newborn Screening market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Revvity, Inc. , Natus Medical Incorporated, Waters Corporation, Bio-Rad Laboratories, Inc., Demant A/S, Masimo Corporation, Trivitron Healthcare, Baebies, Inc., Danaher Corporation, Thermo Fisher Scientific Inc.. The Newborn Screening market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Newborn Screening industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Newborn Screening industry include- Revvity, Inc. , Natus Medical Incorporated, Waters Corporation, Bio-Rad Laboratories, Inc., Demant A/S, Masimo Corporation, Trivitron Healthcare, Baebies, Inc., Danaher Corporation, Thermo Fisher Scientific Inc.. The Newborn Screening market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Newborn Screening Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Newborn Screening market remains one of the strongest-performing segments in the country.
The US Newborn Screening Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Newborn Screening market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Newborn Screening industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Newborn Screening markets
Canada's strong Newborn Screening sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Newborn Screening market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Newborn Screening Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Newborn Screening market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Newborn Screening population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Newborn Screening industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Newborn Screening market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Newborn Screening sales through 2034
France Newborn Screening companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Newborn Screening Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Newborn Screening distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Newborn Screening Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Newborn Screening market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Newborn Screening industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Newborn Screening industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Newborn Screening Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Newborn Screening market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Newborn Screening market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Newborn Screening Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Newborn Screening Market Segmentation
By Product Type
Instruments
Reagents, Consumables and Assay Kits
By Test Type
Dry Blood Spot Tests
Hearing Screening Tests
Critical Congenital Heart Disease (CCHD) / Pulse Oximetry Screening Tests
By Technology
Tandem Mass Spectrometry
Immunoassays and Enzymatic Assays
Molecular/DNA Assays
Electrophoresis
Pulse Oximetry
Other Technologies
By Disease
Critical Congenital Heart Disease (CCHD)
Metabolic Disorders
Endocrine Disorders
Hematological Disorders
Cystic Fibrosis (CF)
Other Genetic and Rare Disorders
Leading Companies in Newborn Screening Industry (2026)
Revvity, Inc.
Natus Medical Incorporated
Waters Corporation
Bio-Rad Laboratories, Inc.
Demant A/S
Masimo Corporation
Trivitron Healthcare
Baebies, Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
Countries Included
The Newborn Screening market report provides detailed analysis and outlook of Newborn Screening segments including By Product Type (Instruments, Reagents, Consumables and Assay Kits), By Test Type (Dry Blood Spot Tests, Hearing Screening Tests, Critical Congenital Heart Disease (CCHD) / Pulse Oximetry Screening Tests), By Technology (Tandem Mass Spectrometry, Immunoassays and Enzymatic Assays, Molecular/DNA Assays, Electrophoresis, Pulse Oximetry, Other Technologies ), By Disease (Critical Congenital Heart Disease (CCHD), Metabolic Disorders, Endocrine Disorders, Hematological Disorders, Cystic Fibrosis (CF), Other Genetic and Rare Disorders) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Newborn Screening Industry Overview
Genomic Technologies Expanding the Scope of Neonatal Diagnostics
The newborn screening industry is undergoing a major transformation as genomic technologies, molecular diagnostics, and precision medicine approaches expand the number of conditions that can be identified shortly after birth. Healthcare systems worldwide are moving beyond conventional biochemical screening toward more comprehensive diagnostic models capable of detecting a wider range of rare genetic, metabolic, and inherited disorders. Early identification of treatable diseases remains the primary objective of newborn screening programs, enabling timely intervention that can significantly improve long-term health outcomes. Advances in sequencing technologies, laboratory automation, and bioinformatics are supporting the evolution of newborn screening from targeted testing toward broader genomic assessment integrated within national healthcare systems.
Genome Sequencing Driving Next-Generation Screening Programs
A major industry trend is the incorporation of genomic sequencing into routine newborn screening workflows. The Rady Children’s Institute for Genomic Medicine expanded this movement through its collaboration with King Faisal Specialist Hospital & Research Centre to implement the BeginNGS® program. The initiative utilizes genome sequencing to screen newborns for more than 1,000 treatable genetic conditions, demonstrating the growing role of genomics in neonatal healthcare. Such programs represent a significant shift from traditional screening approaches by enabling earlier and more comprehensive disease detection. As sequencing technologies become increasingly accessible and clinically validated, healthcare organizations are exploring broader implementation of genomic newborn screening as part of precision medicine strategies aimed at improving disease prevention and early intervention outcomes.
Standardization and Public Health Integration Strengthening Industry Development
The industry is also benefiting from efforts to improve standardization, laboratory quality, and public health integration. Accredia's extension of ISO 15189 accreditation standards to laboratories performing neonatal screening supports greater consistency and reliability across Extended Newborn Screening programs capable of detecting more than 50 rare diseases from a single blood sample. At the same time, regional healthcare initiatives are incorporating advanced molecular technologies into population-wide screening efforts. Revvity is supporting this transition through its participation in Helyx Industries' Genome Project in Italy's Apulia region, where DNA-based analysis is being utilized to identify metabolic disorders and rare diseases at birth. These developments illustrate how newborn screening is increasingly becoming a technologically advanced, standardized, and genomics-driven public health service designed to improve early diagnosis and long-term patient outcomes.
Newborn Screening Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Newborn Screening market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Revvity, Inc. , Natus Medical Incorporated, Waters Corporation, Bio-Rad Laboratories, Inc., Demant A/S, Masimo Corporation, Trivitron Healthcare, Baebies, Inc., Danaher Corporation, Thermo Fisher Scientific Inc.. The Newborn Screening market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Newborn Screening industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Newborn Screening Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Newborn Screening companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Newborn Screening markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Newborn Screening industry include- Revvity, Inc. , Natus Medical Incorporated, Waters Corporation, Bio-Rad Laboratories, Inc., Demant A/S, Masimo Corporation, Trivitron Healthcare, Baebies, Inc., Danaher Corporation, Thermo Fisher Scientific Inc.. The Newborn Screening market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Newborn Screening Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Newborn Screening market remains one of the strongest-performing segments in the country.
The US Newborn Screening Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Newborn Screening market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Newborn Screening industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Newborn Screening markets
Canada's strong Newborn Screening sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Newborn Screening market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Newborn Screening Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Newborn Screening market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Newborn Screening population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Newborn Screening industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Newborn Screening market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Newborn Screening sales through 2034
France Newborn Screening companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Newborn Screening Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Newborn Screening distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Newborn Screening Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Newborn Screening market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Newborn Screening industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Newborn Screening industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Newborn Screening Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Newborn Screening market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Newborn Screening market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Newborn Screening Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Newborn Screening Market Segmentation
By Product Type
Instruments
Reagents, Consumables and Assay Kits
By Test Type
Dry Blood Spot Tests
Hearing Screening Tests
Critical Congenital Heart Disease (CCHD) / Pulse Oximetry Screening Tests
By Technology
Tandem Mass Spectrometry
Immunoassays and Enzymatic Assays
Molecular/DNA Assays
Electrophoresis
Pulse Oximetry
Other Technologies
By Disease
Critical Congenital Heart Disease (CCHD)
Metabolic Disorders
Endocrine Disorders
Hematological Disorders
Cystic Fibrosis (CF)
Other Genetic and Rare Disorders
Leading Companies in Newborn Screening Industry (2026)
Revvity, Inc.
Natus Medical Incorporated
Waters Corporation
Bio-Rad Laboratories, Inc.
Demant A/S
Masimo Corporation
Trivitron Healthcare
Baebies, Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Newborn Screening Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Newborn Screening Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL NEWBORN SCREENING MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Newborn Screening Markets in 2026
3.2. Global Historic and Forecast Newborn Screening Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Newborn Screening Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Newborn Screening Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Newborn Screening Value Chain
CHAPTER 4- NEWBORN SCREENING MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Newborn Screening Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- NEWBORN SCREENING MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Instruments
Reagents, Consumables and Assay Kits
By Test Type
Dry Blood Spot Tests
Hearing Screening Tests
Critical Congenital Heart Disease (CCHD) / Pulse Oximetry Screening Tests
By Technology
Tandem Mass Spectrometry
Immunoassays and Enzymatic Assays
Molecular/DNA Assays
Electrophoresis
Pulse Oximetry
Other Technologies
By Disease
Critical Congenital Heart Disease (CCHD)
Metabolic Disorders
Endocrine Disorders
Hematological Disorders
Cystic Fibrosis (CF)
Other Genetic and Rare Disorders
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA NEWBORN SCREENING MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Newborn Screening Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Newborn Screening Market Trends and Growth Opportunities to 2034
7.5. North America Newborn Screening Market Size Outlook by Type
7.6. North America Newborn Screening Market Size Outlook by Application
7.7. North America Newborn Screening Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Newborn Screening Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Newborn Screening Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Newborn Screening Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Newborn Screening Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Newborn Screening Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Newborn Screening Companies
CHAPTER 8- EUROPE NEWBORN SCREENING MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Newborn Screening Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Newborn Screening Market Trends and Growth Opportunities to 2034
8.5. Europe Newborn Screening Market Size Outlook by Type
8.6. Europe Newborn Screening Market Size Outlook by Application
8.7. Europe Newborn Screening Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Newborn Screening Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Newborn Screening Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Newborn Screening Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Newborn Screening Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Newborn Screening Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Newborn Screening Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Newborn Screening Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Newborn Screening Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Newborn Screening Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Newborn Screening Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Newborn Screening Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Newborn Screening Companies
CHAPTER 9- ASIA PACIFIC NEWBORN SCREENING MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Newborn Screening Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Newborn Screening Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Newborn Screening Market Size Outlook by Type
9.6. Asia Pacific Newborn Screening Market Size Outlook by Application
9.7. Asia Pacific Newborn Screening Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Newborn Screening Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Newborn Screening Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Newborn Screening Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Newborn Screening Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Newborn Screening Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Newborn Screening Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Newborn Screening Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Newborn Screening Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Newborn Screening Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Newborn Screening Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Newborn Screening Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Newborn Screening Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA NEWBORN SCREENING MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Newborn Screening Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Newborn Screening Market Trends and Growth Opportunities to 2034
10.5. South and Central America Newborn Screening Market Size Outlook by Type
10.6. South and Central America Newborn Screening Market Size Outlook by Application
10.7. South and Central America Newborn Screening Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Newborn Screening Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Newborn Screening Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Newborn Screening Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Newborn Screening Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Newborn Screening Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Newborn Screening Companies
CHAPTER 11- MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Newborn Screening Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Newborn Screening Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Newborn Screening Market Size Outlook by Type
11.6. Middle East and Africa Newborn Screening Market Size Outlook by Application
11.7. Middle East and Africa Newborn Screening Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Newborn Screening Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Newborn Screening Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Newborn Screening Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Newborn Screening Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Newborn Screening Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Newborn Screening Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Newborn Screening Industry
Revvity, Inc.
Natus Medical Incorporated
Waters Corporation
Bio-Rad Laboratories, Inc.
Demant A/S
Masimo Corporation
Trivitron Healthcare
Baebies, Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Newborn Screening Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Newborn Screening Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL NEWBORN SCREENING MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Newborn Screening Markets in 2026
3.2. Global Historic and Forecast Newborn Screening Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Newborn Screening Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Newborn Screening Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Newborn Screening Value Chain
CHAPTER 4- NEWBORN SCREENING MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Newborn Screening Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- NEWBORN SCREENING MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Instruments
Reagents, Consumables and Assay Kits
By Test Type
Dry Blood Spot Tests
Hearing Screening Tests
Critical Congenital Heart Disease (CCHD) / Pulse Oximetry Screening Tests
By Technology
Tandem Mass Spectrometry
Immunoassays and Enzymatic Assays
Molecular/DNA Assays
Electrophoresis
Pulse Oximetry
Other Technologies
By Disease
Critical Congenital Heart Disease (CCHD)
Metabolic Disorders
Endocrine Disorders
Hematological Disorders
Cystic Fibrosis (CF)
Other Genetic and Rare Disorders
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA NEWBORN SCREENING MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Newborn Screening Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Newborn Screening Market Trends and Growth Opportunities to 2034
7.5. North America Newborn Screening Market Size Outlook by Type
7.6. North America Newborn Screening Market Size Outlook by Application
7.7. North America Newborn Screening Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Newborn Screening Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Newborn Screening Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Newborn Screening Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Newborn Screening Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Newborn Screening Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Newborn Screening Companies
CHAPTER 8- EUROPE NEWBORN SCREENING MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Newborn Screening Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Newborn Screening Market Trends and Growth Opportunities to 2034
8.5. Europe Newborn Screening Market Size Outlook by Type
8.6. Europe Newborn Screening Market Size Outlook by Application
8.7. Europe Newborn Screening Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Newborn Screening Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Newborn Screening Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Newborn Screening Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Newborn Screening Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Newborn Screening Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Newborn Screening Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Newborn Screening Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Newborn Screening Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Newborn Screening Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Newborn Screening Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Newborn Screening Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Newborn Screening Companies
CHAPTER 9- ASIA PACIFIC NEWBORN SCREENING MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Newborn Screening Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Newborn Screening Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Newborn Screening Market Size Outlook by Type
9.6. Asia Pacific Newborn Screening Market Size Outlook by Application
9.7. Asia Pacific Newborn Screening Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Newborn Screening Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Newborn Screening Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Newborn Screening Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Newborn Screening Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Newborn Screening Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Newborn Screening Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Newborn Screening Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Newborn Screening Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Newborn Screening Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Newborn Screening Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Newborn Screening Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Newborn Screening Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA NEWBORN SCREENING MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Newborn Screening Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Newborn Screening Market Trends and Growth Opportunities to 2034
10.5. South and Central America Newborn Screening Market Size Outlook by Type
10.6. South and Central America Newborn Screening Market Size Outlook by Application
10.7. South and Central America Newborn Screening Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Newborn Screening Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Newborn Screening Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Newborn Screening Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Newborn Screening Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Newborn Screening Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Newborn Screening Companies
CHAPTER 11- MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Newborn Screening Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Newborn Screening Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Newborn Screening Market Size Outlook by Type
11.6. Middle East and Africa Newborn Screening Market Size Outlook by Application
11.7. Middle East and Africa Newborn Screening Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Newborn Screening Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Newborn Screening Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Newborn Screening Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Newborn Screening Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Newborn Screening Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Newborn Screening Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Newborn Screening Industry
Revvity, Inc.
Natus Medical Incorporated
Waters Corporation
Bio-Rad Laboratories, Inc.
Demant A/S
Masimo Corporation
Trivitron Healthcare
Baebies, Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
